(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are NYXOAH, VIVORYON, and GENFIT.

Financial Asset	Price	Change	Updated (EST)
NYXOAH (NYXH.BR)	4.80	13.74%	2024-01-23 12:20:55
VIVORYON (VVY.AS)	8.80	12.24%	2024-01-23 12:04:17
GENFIT (GNFT.PA)	3.70	8.19%	2024-01-23 13:04:03
TF1 (TFI.PA)	8.11	8.06%	2024-01-23 13:23:33
CONTEXTVISION (CONTX.OL)	8.52	7.85%	2024-01-23 12:25:17
OCEANTEAM (OTS.OL)	1.46	6.57%	2024-01-23 12:41:41
BOURSE DIRECT (BSD.PA)	5.30	6.43%	2024-01-23 13:00:31
PLAST.VAL LOIRE (PVL.PA)	3.31	6.43%	2024-01-23 13:21:30
AB SCIENCE (AB.PA)	3.33	6.39%	2024-01-23 12:44:23
NORSK HYDRO (NHY.OL)	62.62	6.35%	2024-01-23 12:41:27

The three biggest losers today are BARBARA BUI, POLIGHT, and NHOA.

Financial Asset	Price	Change	Updated (EST)
BARBARA BUI (BUI.PA)	7.25	-17.14%	2024-01-23 13:00:10
POLIGHT (PLT.OL)	20.25	-8.37%	2024-01-23 12:42:14
NHOA (NHOA.PA)	0.69	-7.24%	2024-01-23 13:20:42
POXEL (POXEL.PA)	0.46	-7.07%	2024-01-23 13:21:33
ATOS (ATO.PA)	3.51	-6.97%	2024-01-23 12:45:42
ACTEOS (EOS.PA)	1.48	-5.13%	2024-01-23 12:44:40
ITERA (ITERA.OL)	12.10	-5.1%	2024-01-23 12:40:37
B.COM.PORTUGUES (BCP.LS)	0.27	-5.01%	2024-01-23 12:22:53
ADUX (ADUX.PA)	1.36	-4.9%	2024-01-23 12:44:49
MPC CONTAINER SHIP (MPCC.OL)	15.10	-4.73%	2024-01-23 12:41:10

Winners today

1. NYXOAH (NYXH.BR)

13.74% Price Change

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with NYXOAH jumping 13.74% to €4.80 on Tuesday while BEL 20 rose 0.16% to €3,598.54.

Earnings Per Share

As for profitability, NYXOAH has a trailing twelve months EPS of €-1.68.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.76%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 436.3%, now sitting on 3.83M for the twelve trailing months.

Volume

Today’s last reported volume for NYXOAH is 34727 which is 60.41% above its average volume of 21648.

More news about NYXOAH.

2. VIVORYON (VVY.AS)

12.24% Price Change

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.

AEX-Index ended the session with VIVORYON jumping 12.24% to €8.80 on Tuesday while AEX-Index rose 0.28% to €787.77.

Earnings Per Share

As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.

Volatility

VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.19%, a negative 0.28%, and a positive 2.13%.

VIVORYON’s highest amplitude of average volatility was 1.96% (last week), 1.53% (last month), and 2.13% (last quarter).

Volume

Today’s last reported volume for VIVORYON is 292118 which is 354.87% above its average volume of 64220.

More news about VIVORYON.

3. GENFIT (GNFT.PA)

8.19% Price Change

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.

CAC 40 ended the session with GENFIT jumping 8.19% to €3.70 on Tuesday, following the last session’s upward trend. CAC 40 dropped 0.34% to €7,388.04, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, GENFIT has a trailing twelve months EPS of €-0.74.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.21%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 24.5%, now sitting on 29.22M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GENFIT’s stock is considered to be oversold (<=20).

More news about GENFIT.

4. TF1 (TFI.PA)

8.06% Price Change

TF1 SA engages in the broadcasting, studios and entertainment, and digital businesses in France and internationally. The company offers DTT channels, including TMC, TFX, and TF1 Séries Films; Theme channels, such as TV Breizh, Ushuaïa TV, and Histoire TV; e-TF1; websites; and advertising services, as well as TF1, which covers sports, French drama, news, entertainment, sports, and movies. It also operates studios, including Newen Studios; TF1 Studio; and entertainment channel comprising TF1 Entertainment. In addition, the company operates Unify, a digital channel. Further, it offers digital content management, theme channel, content/broadcasting internet and TV, and TV news images agency services, as well as engages in the acquisition/sale of audiovisual rights and e-commerce activities. TF1 SA was incorporated in 1982 and is headquartered in Boulogne-Billancourt, France.

CAC 40 ended the session with TF1 rising 8.06% to €8.11 on Tuesday while CAC 40 fell 0.34% to €7,388.04.

Earnings Per Share

As for profitability, TF1 has a trailing twelve months EPS of €0.78.

PE Ratio

TF1 has a trailing twelve months price to earnings ratio of 10.4. Meaning, the purchaser of the share is investing €10.4 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.82%.

More news about TF1.

5. CONTEXTVISION (CONTX.OL)

7.85% Price Change

ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and the United States. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and veterinary. Its products include Rivent that offers unparalleled image quality for various types of ultrasound systems for women's health, general imaging, cardiovascular, and point of care applications; Rivent Mobile, an enhancing ultrasound image for the handheld ultrasound devices using mobile phones and tablets; and Rivent 3D, an image enhancement product for 3D ultrasound. The company also provides Altumira/Altumira Plus, a platform for digital radiography; and Orthopedic Package for orthopedic imaging. In addition, it offers GOPView MRI2Plus, an image enhancement solution for MRI. The company was founded in 1983 and is headquartered in Stockholm, Sweden.

Oslo Børs Benchmark Index_GI ended the session with CONTEXTVISION jumping 7.85% to €8.52 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.48% to €1,284.39, after three successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, CONTEXTVISION has a trailing twelve months EPS of kr0.47.

PE Ratio

CONTEXTVISION has a trailing twelve months price to earnings ratio of 18.13. Meaning, the purchaser of the share is investing kr18.13 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 61.1%.

Volume

Today’s last reported volume for CONTEXTVISION is 111094 which is 105.36% above its average volume of 54095.

Moving Average

CONTEXTVISION’s value is higher than its 50-day moving average of kr8.37 and below its 200-day moving average of kr8.72.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Nov 2, 2023, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 3.46%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

CONTEXTVISION’s EBITDA is 49.39.

More news about CONTEXTVISION.

6. OCEANTEAM (OTS.OL)

6.57% Price Change

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM rising 6.57% to €1.46 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.48% to €1,284.39.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.31.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.62%.

More news about OCEANTEAM.

7. BOURSE DIRECT (BSD.PA)

6.43% Price Change

Bourse Direct SA provides Internet stock brokerage services in France. It offers a platform of services, tools, and financial products, including French and foreign equities, derivatives, trackers, warrants, certificates, turbos, mutual funds, UCITS, and CFDs, as well as tax exemption, retirement, real estate, and life insurance products through the boursedirect.fr, capitol.fr, tradebox.fr, abssysteme.fr, wargny.com, and mesactions.com sites. The company was founded in 1996 and is headquartered in Paris, France. Bourse Direct SA is a subsidiary of E-VIEL SA. Bourse Direct et Bourse Discount SA provides French and foreign equities, derivatives, trackers, warrants, certificates, turbos, UCITS, CFDs, tax exemption products, real estate products, and direct horizon stock exchange life insurance contracts. The company was was incorporated in 1996 and is based in Paris, France.

CAC 40 ended the session with BOURSE DIRECT rising 6.43% to €5.30 on Tuesday while CAC 40 fell 0.34% to €7,388.04.

Earnings Per Share

As for profitability, BOURSE DIRECT has a trailing twelve months EPS of €0.18.

PE Ratio

BOURSE DIRECT has a trailing twelve months price to earnings ratio of 29.44. Meaning, the purchaser of the share is investing €29.44 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.89%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 29.5%, now sitting on 55.59M for the twelve trailing months.

Volume

Today’s last reported volume for BOURSE DIRECT is 7804 which is 22.7% below its average volume of 10097.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 22, 2023, the estimated forward annual dividend rate is 0.08 and the estimated forward annual dividend yield is 1.56%.

More news about BOURSE DIRECT.

8. PLAST.VAL LOIRE (PVL.PA)

6.43% Price Change

Plastiques du Val de Loire engages in the production and sale of plastic parts in France, North America, and internationally. The company offers interior equipment for vehicles, such as cockpits, decoration products, and mechanisms; exterior appearance parts; technical front facades; seat parts; lighting and signaling products; and under the hood parts. It also manufactures plastic products for use in construction and electricity, household electrical appliances, multimedia, leisure and garden, and luxury/design markets. The company was founded in 1963 and is headquartered in Langeais, France.

CAC 40 ended the session with PLAST.VAL LOIRE jumping 6.43% to €3.31 on Tuesday while CAC 40 dropped 0.34% to €7,388.04.

Earnings Per Share

As for profitability, PLAST.VAL LOIRE has a trailing twelve months EPS of €-1.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.52%.

Moving Average

PLAST.VAL LOIRE’s value is above its 50-day moving average of €3.03 and way above its 200-day moving average of €2.95.

More news about PLAST.VAL LOIRE.

9. AB SCIENCE (AB.PA)

6.39% Price Change

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with AB SCIENCE jumping 6.39% to €3.33 on Tuesday, after five consecutive sessions in a row of losses. CAC 40 slid 0.34% to €7,388.04, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.36.

Revenue Growth

Year-on-year quarterly revenue growth declined by 28.8%, now sitting on 777k for the twelve trailing months.

Moving Average

AB SCIENCE’s value is above its 50-day moving average of €3.07 and way below its 200-day moving average of €3.70.

More news about AB SCIENCE.

10. NORSK HYDRO (NHY.OL)

6.35% Price Change

Norsk Hydro ASA engages in the power production, bauxite extraction, alumina refining, aluminium smelting, remelting, and recycling activities; and provision of extruded solutions worldwide. It operates through Hydro Bauxite & Alumina, Hydro Aluminium Metal, Hydro Metal Markets, Hydro Extrusions, and Hydro Energy segments. The Hydro Bauxite & Alumina segment engages in bauxite mining activities, production of alumina, and related commercial activities, primarily the sale of alumina. The Hydro Aluminium Metal segment is involved in the primary aluminum production casting activities. This segment principally offers extrusion ingots, foundry alloys, and sheet and standard ingots. The Metal Markets segment sells products from the company's primary metal plants; operates recyclers; and trades in physical and financial metals. The Hydro Extrusions segment offers extrusion profiles, building systems, and precision tubing products for construction, automotive and heating, and ventilation and air conditioning sectors, as well as operates recycling facilities. The Hydro Energy segment engages in the trading and wholesale business in Brazil; energy sourcing operations; and operation of power stations in Norway, as well as renewable energy production, such as wind and solar, battery, and hydrogen. Norsk Hydro ASA was founded in 1905 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORSK HYDRO rising 6.35% to €62.62 on Tuesday, after five successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.48% to €1,284.39, after three sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, NORSK HYDRO has a trailing twelve months EPS of kr3.14.

PE Ratio

NORSK HYDRO has a trailing twelve months price to earnings ratio of 19.94. Meaning, the purchaser of the share is investing kr19.94 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.19%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORSK HYDRO’s stock is considered to be overbought (>=80).

Sales Growth

NORSK HYDRO’s sales growth is 0.1% for the current quarter and negative 1.9% for the next.

Yearly Top and Bottom Value

NORSK HYDRO’s stock is valued at kr62.62 at 21:40 EST, way below its 52-week high of kr83.56 and way higher than its 52-week low of kr56.62.

More news about NORSK HYDRO.

Losers Today

1. BARBARA BUI (BUI.PA)

-17.14% Price Change

Barbara Bui SA engages in the manufacture, marketing, and sale of ready-to-wear clothing and accessories for women in France and internationally. The company offers coats, jackets, tops and shirts, T-shirts, mesh, pants, dresses and skirts, leather products, and tailored cloths; and accessories, such as shoes, bags, scarves, and belts. It offers its products through wholesale distributors, as well as online and offline stores. The company was incorporated in 1982 and is based in Paris, France.

CAC 40 ended the session with BARBARA BUI sliding 17.14% to €7.25 on Tuesday while CAC 40 slid 0.34% to €7,388.04.

Earnings Per Share

As for profitability, BARBARA BUI has a trailing twelve months EPS of €1.04.

PE Ratio

BARBARA BUI has a trailing twelve months price to earnings ratio of 6.97. Meaning, the purchaser of the share is investing €6.97 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 125.51%.

Volume

Today’s last reported volume for BARBARA BUI is 10 which is 66.66% below its average volume of 30.

Moving Average

BARBARA BUI’s worth is way below its 50-day moving average of €8.43 and way below its 200-day moving average of €8.35.

Yearly Top and Bottom Value

BARBARA BUI’s stock is valued at €7.25 at 21:40 EST, way below its 52-week high of €10.50 and way above its 52-week low of €6.30.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Sep 15, 2009, the estimated forward annual dividend yield is 4.08%.

More news about BARBARA BUI.

2. POLIGHT (PLT.OL)

-8.37% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; ASIC drivers, which control the supply of variable voltage to Tlens products and makes them to change focus; TLens Silver and TLens Silver Premium devices; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. it serves smartphones and wearables, barcode/industrial, augmented reality, medical endoscopy, webcams, and other markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT sliding 8.37% to €20.25 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.48% to €1,284.39, after three successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.27%.

Volume

Today’s last reported volume for POLIGHT is 836197 which is 104.53% above its average volume of 408838.

Earnings Before Interest, Taxes, Depreciation, and Amortization

POLIGHT’s EBITDA is -39.19.

Revenue Growth

Year-on-year quarterly revenue growth declined by 42.1%, now sitting on 21.46M for the twelve trailing months.

More news about POLIGHT.

3. NHOA (NHOA.PA)

-7.24% Price Change

NHOA S.A. provides energy storage, E-mobility, and EV fastcharging infrastructure related solutions in France. The company offers solar plus storage, utility-scale storage, and industrial microgrids. It also provides charging services and devices for electric and hybrid vehicles. In addition, the company offers power house, and hybrid house; and HyESS, a technology platform for the transformation of renewables into sustainable grids, as well as Atlante, an eStation that provides fast charging solution. NHOA S.A. is based in Paris, France.

CAC 40 ended the session with NHOA sliding 7.24% to €0.69 on Tuesday while CAC 40 fell 0.34% to €7,388.04.

Earnings Per Share

As for profitability, NHOA has a trailing twelve months EPS of €-1.9.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -94.09%.

Volume

Today’s last reported volume for NHOA is 122454 which is 27.73% above its average volume of 95868.

Revenue Growth

Year-on-year quarterly revenue growth grew by 48.4%, now sitting on 203.51M for the twelve trailing months.

Yearly Top and Bottom Value

NHOA’s stock is valued at €0.69 at 21:40 EST, way below its 52-week high of €9.16 and way above its 52-week low of €0.59.

Volatility

NHOA’s last week, last month’s, and last quarter’s current intraday variation average was 1.70%, 1.28%, and 2.85%.

NHOA’s highest amplitude of average volatility was 3.11% (last week), 3.65% (last month), and 2.85% (last quarter).

More news about NHOA.

4. POXEL (POXEL.PA)

-7.07% Price Change

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.

CAC 40 ended the session with POXEL dropping 7.07% to €0.46 on Tuesday, following the last session’s upward trend. CAC 40 slid 0.34% to €7,388.04, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, POXEL has a trailing twelve months EPS of €-1.08.

Volatility

POXEL’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.89%, a negative 0.81%, and a positive 5.31%.

POXEL’s highest amplitude of average volatility was 11.40% (last week), 6.99% (last month), and 5.31% (last quarter).

Moving Average

POXEL’s value is above its 50-day moving average of €0.42 and way under its 200-day moving average of €0.53.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1050.6%, now sitting on 1.55M for the twelve trailing months.

More news about POXEL.

5. ATOS (ATO.PA)

-6.97% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS sliding 6.97% to €3.51 on Tuesday while CAC 40 dropped 0.34% to €7,388.04.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-10.01.

Volume

Today’s last reported volume for ATOS is 1853950 which is 2.58% below its average volume of 1903130.

Volatility

ATOS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.39%, a negative 3.73%, and a positive 4.39%.

ATOS’s highest amplitude of average volatility was 9.17% (last week), 5.80% (last month), and 4.39% (last quarter).

More news about ATOS.

6. ACTEOS (EOS.PA)

-5.13% Price Change

ACTEOS S.A. designs, develops, integrates, and provides software and related services in the field of supply chain management in France, Germany, and Lebanon. It offers Acteos suite, which include forecasting and procurement system for forecast and point of sales/e-business procurement optimization services; transportation management system to organize and manage transport activities; and warehouse management system, a modular solution to manage customers' warehouses. The company also provides mobility, software as a service, hotline, technical project management, and consulting services. ACTEOS S.A. was founded in 1986 and is headquartered in Roubaix, France.

CAC 40 ended the session with ACTEOS dropping 5.13% to €1.48 on Tuesday, following the last session’s upward trend. CAC 40 dropped 0.34% to €7,388.04, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, ACTEOS has a trailing twelve months EPS of €-0.06.

Volatility

ACTEOS’s last week, last month’s, and last quarter’s current intraday variation average was 0.77%, 1.61%, and 2.39%.

ACTEOS’s highest amplitude of average volatility was 3.46% (last week), 2.88% (last month), and 2.39% (last quarter).

Moving Average

ACTEOS’s worth is way higher than its 50-day moving average of €1.28 and above its 200-day moving average of €1.43.

More news about ACTEOS.

7. ITERA (ITERA.OL)

-5.1% Price Change

Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ITERA falling 5.1% to €12.10 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.48% to €1,284.39.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.76.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 15.92. Meaning, the purchaser of the share is investing kr15.92 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 86.07%.

More news about ITERA.

8. B.COM.PORTUGUES (BCP.LS)

-5.01% Price Change

Banco Comercial Português, S.A., a private sector bank, engages in the provision of various banking and financial products and services in Portugal and internationally. It operates through Retail Banking; Companies, Corporate & Investment Banking; Private Banking; Foreign Business; and Other segments. It offers a range of financial products and services, including current accounts, payment systems, savings and investment products, private banking, asset management, and investment banking services, such as mortgage loans, personal loans, commercial banking, leasing, factoring and insurance, and others. The company is also involved in the provision of investment fund and real estate management, e-commerce, web portal, real estate investment fund, trade finance, trust, consulting, brokerage, marketing, and real estate services, as well as internet, telephone, and mobile banking services. Banco Comercial Português, S.A. was incorporated in 1985 and is based in Porto, Portugal.

PSI ended the session with B.COM.PORTUGUES falling 5.01% to €0.27 on Tuesday, following the last session’s upward trend. PSI slid 1.06% to €6,268.80, following the last session’s upward trend on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, B.COM.PORTUGUES has a trailing twelve months EPS of €0.06.

PE Ratio

B.COM.PORTUGUES has a trailing twelve months price to earnings ratio of 4.55. Meaning, the purchaser of the share is investing €4.55 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.68%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 23.6%, now sitting on 3.32B for the twelve trailing months.

More news about B.COM.PORTUGUES.

9. ADUX (ADUX.PA)

-4.9% Price Change

AdUX SA provides advertising services in France, Belgium, Italy, Spain, Germany, the Netherlands, and internationally. It provides non-intrusive advertising, in-content advertising, brand content, and geomarketing services. The company was founded in 1996 and is headquartered in Paris, France.

CAC 40 ended the session with ADUX sliding 4.9% to €1.36 on Tuesday while CAC 40 slid 0.34% to €7,388.04.

Earnings Per Share

As for profitability, ADUX has a trailing twelve months EPS of €0.72.

PE Ratio

ADUX has a trailing twelve months price to earnings ratio of 1.89. Meaning, the purchaser of the share is investing €1.89 for every euro of annual earnings.

Volatility

ADUX’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.36%, a positive 1.49%, and a positive 2.78%.

ADUX’s highest amplitude of average volatility was 4.97% (last week), 3.60% (last month), and 2.78% (last quarter).

More news about ADUX.

10. MPC CONTAINER SHIP (MPCC.OL)

-4.73% Price Change

MPC Container Ships ASA owns and operates a portfolio of container vessels. The company focuses on small-to mid-size vessels that are chartered out on time-charter contracts to global and regional liner shipping companies serving intra-regional trade lanes. It operates a fleet of 62 vessels with an aggregate capacity of approximately 134,270 twenty-foot equivalent units. MPC Container Ships ASA was incorporated in 2017 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with MPC CONTAINER SHIP sliding 4.73% to €15.10 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.48% to €1,284.39.

Earnings Per Share

As for profitability, MPC CONTAINER SHIP has a trailing twelve months EPS of kr9.32.

PE Ratio

MPC CONTAINER SHIP has a trailing twelve months price to earnings ratio of 1.62. Meaning, the purchaser of the share is investing kr1.62 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.99%.

More news about MPC CONTAINER SHIP.

Stay up to date with our winners and losers daily report